Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.43
+0.10 (1.88%)
Mar 25, 2026, 4:00 PM EDT - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $432.62 million as of March 25, 2026. Its market cap has increased by 73.23% in one year.
Market Cap
432.62M
Enterprise Value
131.63M
1-Year Change
73.23%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $432.62M, a decrease of -77.67%. That is a compound annual growth rate of -24.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 432.62M | 55.11% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 447.08M |
| Absci | 446.82M |
| Invivyd | 440.85M |
| REGENXBIO | 436.65M |
| Eupraxia Pharmaceuticals | 436.23M |
| Ginkgo Bioworks Holdings | 433.68M |
| Aclaris Therapeutics | 432.94M |
| Altimmune | 430.53M |